May 29, 2007 -- The US Food and Drug Administration (FDA) has has approved a supplemental biologics license application for a liquid fibrin sealant for vascular surgery, and granted 510(k) clearances ...
The FDA has approved the use of Omrix Biopharmaceuticals’ Evicel (human liquid fibrin sealant) for general hemostasis in surgery.Evicel is an aprotinin-free formulation indicated as an adjunct to ...
NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“Omrix” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and ...
The U.S. Food and Drug Administration (FDA) today approved Evicel Fibrin Sealant, a liquid product that when applied topically helps control oozing from small blood vessels during surgical procedures.
Findings from a pediatric trial showed 96.7% of the Vistaseal arm achieved hemostasis by 4 minutes compared with 95.4% of the Evicel arm. The Food and Drug Administration (FDA) has expanded the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results